ORIENT BIO Inc. (KRX:002630)

South Korea flag South Korea · Delayed Price · Currency is KRW
538.00
-12.00 (-2.18%)
Feb 5, 2026, 3:30 PM KST
-64.44%
Market Cap63.55B -71.3%
Revenue (ttm)59.09B +19.5%
Net Income-6.85B
EPS-57.81
Shares Out118.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume527,561
Average Volume817,344
Open550.00
Previous Close550.00
Day's Range534.00 - 552.00
52-Week Range521.00 - 2,560.00
Beta0.14
RSI43.62
Earnings Daten/a

About ORIENT BIO

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1959
Employees 125
Stock Exchange Korea Stock Exchange
Ticker Symbol 002630
Full Company Profile

Financial Performance

In fiscal year 2021, ORIENT BIO's revenue was 52.02 billion, an increase of 39.79% compared to the previous year's 37.21 billion. Losses were -15.63 billion, 30.3% more than in 2020.

Financial Statements